I don’t have an explanation for why this JV didn’t work out. ABT makes very good money from selling branded generics in emerging markets, so I don’t see why PFE couldn’t do it.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”